key: cord-0050421-534oqe6a
authors: Ong, Jacqueline S. M.; Tosoni, Alvise; Kim, YaeJean; Kissoon, Niranjan; Murthy, Srinivas
title: The authors reply
date: 2020-09-14
journal: Pediatr Crit Care Med
DOI: 10.1097/pcc.0000000000002569
sha: 35ceda013fb93b083bad69f8f9b819110edd45a8
doc_id: 50421
cord_uid: 534oqe6a

nan

The authors reply: I t is well recognized in the current coronavirus disease 2019 (COVID-19) pandemic that disease patterns in children are different compared with adults (1), recently published in Pediatric Critical Care Medicine. The disease has been milder and we are still discovering its varied manifestations in the critically ill, such as multisystemic inflammatory syndrome of children and adolescents. There are many unknowns and the pathogenesis, clinical features, and therapeutic options are likely to be revealed over time. We thank Lanziotti et al (2) for their thoughtful letter, highlighting the many unknowns with COVID-19 in children, revealing theories of immunopathogenesis in children, and how that could impact acute disease and the development of immunity, including vaccine design.

These are fundamental questions that the global community needs urgent answers on, and we encourage all of the readers to ensure maximal collaboration to answer these questions together. Given the relative rarity of pediatric disease requiring hospitalization or critical care, combining data, both biological and clinical, should be a fundamental goal of our community at this time. Understanding disease in children will provide tremendous insight into preventing and managing it across age groups, as well as guide population health interventions.

Coronavirus disease 2019 in critically ill children: A narrative review of the literature

Understanding Immunopathogenesis Is the "Holy Grail" to Explain Why Children Have Less Severe Acute Disease. Pediatr Crit Care Med

Copyright © 2020 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

The authors have disclosed that they do not have any potential conflicts of interest.